Abstract: A medical device communication method that may be implemented within a variety of medical devices including but not limited to infusion pumps. The method may be implemented with a protocol stack for at least intra-device communication. Embodiments provide connection-oriented, connectionless-oriented, broadcast and multicast data exchange with priority handling of data, fragmentation, and reassembly of data, unique static and dynamic address assignment and hot swap capability for connected peripherals or subsystems.

Abstract: A system and method for tracking and administering liquid medications in a hospital, clinic, or patient residence, including encoding information onto a short range communication device affixed to a liquid container in a hospital pharmaceutical filling or compounding center, the information including drug information, patient information, and IV administration information, transferring the liquid container to a patient's bedside, programming an infusion course into a bedside IV infusion pump by enabling the pump to read the encoded information on the communication device, and disposing of the liquid container and any residual drug in a smart disposal bin that reads the communication device and weighs the container. The disposal bin may confirm the chemical contents of the container.

Abstract: A medical device communication method that may be implemented within a variety of medical devices including but not limited to infusion pumps. The method may be implemented with a protocol stack for at least intra-device communication. Embodiments provide connection-oriented, connectionless-oriented, broadcast and multicast data exchange with priority handling of data, fragmentation, and reassembly of data, unique static and dynamic address assignment and hot swap capability for connected peripherals or subsystems.

Abstract: A tank filler tube includes a fill tube line which features, in the tank assembled state, an inlet end further from the tank, which is designed for temporary insertion of the fill nozzle into a closer-to-the-tank insertion region of the fill tube line, and with a closer-to-the-tank transit line end in the tank assembled state, which is designed for transit of liquid in a direction of the liquid transit line leading away from the inlet end, wherein the fill tube line is of multi-part design. At least one part of the ventilation line is for venting the gas displaced during a filling of a tank into the atmosphere. The fill tube line section featuring the transit line end extends into the insertion region further from the tank and is designed to accommodate at least one outlet end of a fill nozzle during a filling of a tank.

Abstract: New N-(2,6-diethylphenyl)-8-({4-[4-(dimethyl amino)piperidin-1-yl]-2-methoxyphenyl}amino)-1-methyl-4,5-dihydro-1H-pyrazolo[4,3-h]quinazoline-3-carboxamide phosphate of formula (II): Medicaments

Abstract: A medical device communication method that may be implemented within a variety of medical devices including but not limited to infusion pumps. The method may be implemented with a protocol stack for at least intra-device communication. Embodiments provide connection-oriented, connectionless-oriented, broadcast and multicast data exchange with priority handling of data, fragmentation, and reassembly of data, unique static and dynamic address assignment and hot swap capability for connected peripherals or subsystems.

Abstract: The object of the present invention relates to the new and surprising use of sulfated hyaluronic acid (HAS) as regulator agent of the cytokine activity (pro- and anti-inflammatory) and consequently the use of HAS for the preparation of a new medicine for topic use in the prevention and treatment of pathologies associated with the activation and/or deficiency of cytokines of a pro- and anti-inflammatory nature. The Applicant has in fact discovered the exclusive capacity of HAS in modulating the activity of these particular proteins, it has studied the action mechanism and demonstrated the substantial difference between the different sulfated types known in the state of the art, but above all it has demonstrated an unexpectedly high activity of HAS vs different types and strains of Herpes virus, Cytomegalovirus and the virus of vesicular stomatitis. Finally, a further object of the present invention is the use of HAS as a skin absorption promoter of drugs of an anti-inflammatory nature.

Abstract: The object of the present invention relates to the new and surprising use of sulfated hyaluronic acid (HAS) as regulator agent of the cytokine activity (pro- and anti-inflammatory) and consequently the use of HAS for the preparation of a new medicine for topic use in the prevention and treatment of pathologies associated with the activation and/or deficiency of cytokines of a pro- and anti-inflammatory nature. The Applicant has in fact discovered the exclusive capacity of HAS in modulating the activity of these particular proteins, it has studied the action mechanism and demonstrated the substantial difference between the different sulfated types known in the state of the art, but above all it has demonstrated an unexpectedly high activity of HAS vs different types and strains of Herpes virus, Cytomegalovirus and the virus of vesicular stomatitis. Finally, a further object of the present invention is the use of HAS as a skin absorption promoter of drugs of an anti-inflammatory nature.

Abstract: A medical device communication method that may be implemented within a variety of medical devices including but not limited to infusion pumps. The method may be implemented with a protocol stack for at least intra-device communication. Embodiments provide connection-oriented, connectionless-oriented, broadcast and multicast data exchange with priority handling of data, fragmentation, and reassembly of data, unique static and dynamic address assignment and hot swap capability for connected peripherals or subsystems.

Abstract: A tank filler neck including a filling line having an insertion end further away from the tank, designed to temporarily insert a breather pipe into the end region of the filling line further away from the tank, a passage line end closer to the tank, designed for passing through liquid in the direction away from the insertion end, a ventilation volume designed for through-flowing gas while passing liquid through the end of the passage line, a ventilation line which ends at a distance from the filling line and which can be blocked or released by a ventilation valve for through-flowing gas, a detecting device designed to detect a passage-ready state and/or a passage state of the filling line, and an operating device designed to adjust, as a function of the detection result of the detecting device, the ventilation valve between the blocking position and the release position.

Abstract: A method of potentiating cardiac regeneration with neuregulin treatment in a subject in need thereof. The method comprising administering to the subject a therapeutic effective amount of an agent which upregulates activity or expression of ErbB-2, thereby potentiating cardiac regeneration with neuregulin treatment.

Abstract: A beamforming method employs a plurality of microphones arranged in an array with respect to a reference point. The method includes acquiring microphone signals from the microphones and combining the microphone signals (x1 . . .

Abstract: A beamforming method employs a plurality of microphones arranged in an array with respect to a reference point. The method includes acquiring microphone signals from the microphones and combining the microphone signals (x1 . . .

Abstract: A medical device communication method that may be implemented within a variety of medical devices including but not limited to infusion pumps. The method may be implemented with a protocol stack for at least intra-device communication. Embodiments provide connection-oriented, connectionless-oriented, broadcast and multicast data exchange with priority handling of data, fragmentation, and reassembly of data, unique static and dynamic address assignment and hot swap capability for connected peripherals or subsystems.

Abstract: A medical device communication method that may be implemented within a variety of medical devices including but not limited to infusion pumps. The method may be implemented with a protocol stack for at least intra-device communication. Embodiments provide connection-oriented, connectionless-oriented, broadcast and multicast data exchange with priority handling of data, fragmentation, and reassembly of data, unique static and dynamic address assignment and hot swap capability for connected peripherals or subsystems.

Abstract: The object of the present invention relates to the new and surprising use of sulfated hyaluronic acid (HAS) as regulator agent of the cytokine activity (pro- and anti-inflammatory) and consequently the use of HAS for the preparation of a new medicine for topic use in the prevention and treatment of pathologies associated with the activation and/or deficiency of cytokines of a pro- and anti-inflammatory nature. The Applicant has in fact discovered the exclusive capacity of HAS in modulating the activity of these particular proteins, it has studied the action mechanism and demonstrated the substantial difference between the different sulfated types known in the state of the art, but above all it has demonstrated an unexpectedly high activity of HAS vs different types and strains of Herpes virus, Cytomegalovirus and the virus of vesicular stomatitis. Finally, a further object of the present invention is the use of HAS as a skin absorption promoter of drugs of an anti-inflammatory nature.

Abstract: A tank filler tube includes a fill tube line which features, in the tank assembled state, an inlet end further from the tank, which is designed for temporary insertion of the fill nozzle into a closer-to-the-tank insertion region of the fill tube line, and with a closer-to-the-tank transit line end in the tank assembled state, which is designed for transit of liquid in a direction of the liquid transit line leading away from the inlet end, wherein the fill tube line is of multi-part design. At least one part of the ventilation line is for venting the gas displaced during a filling of a tank into the atmosphere. The fill tube line section featuring the transit line end extends into the insertion region further from the tank and is designed to accommodate at least one outlet end of a fill nozzle during a filling of a tank.

Abstract: The object of the present invention relates to the new and surprising use of sulfated hyaluronic acid (HAS) as regulator agent of the cytokine activity (pro- and anti-inflammatory) and consequently the use of HAS for the preparation of a new medicine for topic use in the prevention and treatment of pathologies associated with the activation and/or deficiency of cytokines of a pro- and anti-inflammatory nature. The Applicant has in fact discovered the exclusive capacity of HAS in modulating the activity of these particular proteins, it has studied the action mechanism and demonstrated the substantial difference between the different sulfated types known in the state of the art, but above all it has demonstrated an unexpectedly high activity of HAS vs different types and strains of Herpes virus, Cytomegalovirus and the virus of vesicular stomatitis. Finally, a further object of the present invention is the use of HAS as a skin absorption promoter of drugs of an anti-inflammatory nature.

Abstract: A method of potentiating cardiac regeneration with neuregulin treatment in a subject in need thereof. The method comprising administering to the subject a therapeutic effective amount of an agent which upregulates activity or expression of ErbB-2, thereby potentiating cardiac regeneration with neuregulin treatment.

Abstract: A tank filler neck including a filling line having an insertion end further away from the tank, designed to temporarily insert a breather pipe into the end region of the filling line further away from the tank, a passage line end closer to the tank, designed for passing through liquid in the direction away from the insertion end, a ventilation volume designed for through-flowing gas while passing liquid through the end of the passage line, a ventilation line which ends at a distance from the filling line and which can be blocked or released by a ventilation valve for through-flowing gas, a detecting device designed to detect a passage-ready state and/or a passage state of the filling line, and an operating device designed to adjust, as a function of the detection result of the detecting device, the ventilation valve between the blocking position and the release position.